Alimera Sciences reported $2.01M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Alimera Sciences ALIM:US USD 2.01M 160K
Bayer BAYN:GR EUR 4.25B 1.43B
Insmed INSM:US USD 13.47M 2.92M
Novartis NOVN:VX USD 3.66B 92M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Roche Holding ROG:VX 9.56B 717M